As this field continues to rapidly grow and delivery mechanisms significantly improve, these types of approaches could become much more feasible, opening the door to an exciting and potentially highly effective method of restoring functional PTEN in PTEN-deficient prostate cancer. This evidence concerns the gene PTEN and prostate cancer.